| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385990A1 Compositions having improved stability |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385865A1 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine a3 receptor affinitive agents |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385737A1 Piperazine derivatives as 5-ht1b antagonists |
| 04/05/2001 | CA2385490A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2385001A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | CA2384692A1 Novel tropane analogs |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384265A1 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |
| 04/05/2001 | CA2381771A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | CA2379595A1 Oral controlled release formulations |
| 04/05/2001 | CA2352194A1 Azepinoindole derivatives, the production and use thereof |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1088822A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1088818A1 Quinolin-4-yl derivatives |
| 04/04/2001 | EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/04/2001 | EP1088550A1 alpha-sulfonylamino hydroxamic acid inhibitors of matrix metallo-proteinases for the treatment of peripheral or central nervous system disorders |
| 04/04/2001 | EP1088549A1 Modafinil having defined particle size |
| 04/04/2001 | EP1088104A2 Methods for treating a neurological disease by determining bche genotype |
| 04/04/2001 | EP1088079A2 Nek-related and bub1-related protein kinases |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087973A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 04/04/2001 | EP1087972A1 Triazolo-pyrimidines as ligands for gaba receptors |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087968A1 Triazolo-pyridine derivatives as ligands for gaba receptors |
| 04/04/2001 | EP1087966A1 Chemical synthesis of morpholine derivatives |
| 04/04/2001 | EP1087964A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 04/04/2001 | EP1087954A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 04/04/2001 | EP1087950A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087782A1 Regulation of tyrosine hydroxylase |
| 04/04/2001 | EP1087781A1 Dietary supplement for supporting cerebrovascular tone |
| 04/04/2001 | EP1087775A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 04/04/2001 | EP1087771A1 Use of a nk-1 receptor antagonist for treating bipolar disorders |
| 04/04/2001 | EP1087768A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 04/04/2001 | EP1087766A1 Method of treatment |
| 04/04/2001 | EP1087765A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| 04/04/2001 | EP1087763A1 Neurotrophic difluoroamide agents |
| 04/04/2001 | EP1087762A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 04/04/2001 | EP1087761A2 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| 04/04/2001 | EP0828489A4 Smoking cessation treatments using naltrexone and related compounds |
| 04/04/2001 | CN1290349A Pharmaceutical grade ginkgo biloba |
| 04/04/2001 | CN1290303A Use of negative regulation elements for nerve-specific expression of transgenes |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290262A Heteroaromatic derivatives |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1290166A Treatment of Dyskinesie |
| 04/04/2001 | CN1289617A Medicine for treating neuropathy and its preparing process |
| 04/04/2001 | CN1289613A Liquid medicine for treating eel furor and its preparing process |
| 04/04/2001 | CN1289607A Capsule for treating epilepsy |
| 04/04/2001 | CN1289599A Plaster for treating infantile nervous fever |
| 04/04/2001 | CN1289593A Application of oligose mixture in treating stress brain injury |
| 04/04/2001 | CN1289592A Application of oligose treating stress brain injury |
| 04/04/2001 | CN1063948C Isatis root preparation and compounding process and use thereof |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211372 Pharmaceutical compositions and methods for use |
| 04/03/2001 | US6211368 Hydrolysis of corresponding ester |
| 04/03/2001 | US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity |
| 04/03/2001 | US6211366 Psychological, nervous system disorders |
| 04/03/2001 | US6211364 Process for preparing indane-like compounds |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211225 Sleep disorders and circadian rhythm disorders |
| 04/03/2001 | US6211211 Anxiolytic, anticonvulsant and antiepileptic agent |
| 04/03/2001 | US6211210 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211195 Nervous system, psychological and glandular disorders |
| 04/03/2001 | US6211194 Solution containing nicotine |
| 04/03/2001 | US6211189 Nitric oxide synthase inhibitors; antiinflammatory agents, analgesics |
| 04/03/2001 | US6211187 Post-traumatic stress; antidepressants, anxiolytic agents |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211173 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210705 Flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours. |
| 04/03/2001 | CA2224795C Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/03/2001 | CA2200169C Triazole antifungal agents |
| 04/03/2001 | CA2023951C N-hydroxy-dibenz¢b,e!oxepin -alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments |